Release Date: 16/10/15 17:02 Summary: Change in substantial holding - NAB Price Sensitive: No Download Document 453.31KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%